Stability study over time of clinical solutions of ziv-aflibercept prepared in infusion bags using a proper combination of physicochemical and functional strategies

Hermosilla, J; Perez-Robles, R; Salmeron-Garcia, A; Casares, S; Cabeza, J; Navas, N

Navas, N (corresponding author), Fuentenueva Ave S-N, Granada 18071, Spain.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2021; 203 ():

Abstract

A range of biopharmaceutical products are used to target Vascular Endothelial Growth Factor (VEGF), including Eylea (R) (aflibercept, AFL) and Zaltrap......

Full Text Link